Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 1
2005 1
2006 1
2007 1
2008 2
2009 4
2010 2
2011 1
2012 1
2013 5
2014 4
2015 4
2016 4
2017 2
2018 6
2019 5
2020 5
2021 7
2022 6
2023 12
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean kentamiki (3 results)?
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.
Smith MR, Hussain M, Saad F, Fizazi K, Sternberg CN, Crawford ED, Kopyltsov E, Park CH, Alekseev B, Montesa-Pino Á, Ye D, Parnis F, Cruz F, Tammela TLJ, Suzuki H, Utriainen T, Fu C, Uemura M, Méndez-Vidal MJ, Maughan BL, Joensuu H, Thiele S, Li R, Kuss I, Tombal B; ARASENS Trial Investigators. Smith MR, et al. N Engl J Med. 2022 Mar 24;386(12):1132-1142. doi: 10.1056/NEJMoa2119115. Epub 2022 Feb 17. N Engl J Med. 2022. PMID: 35179323 Free PMC article. Clinical Trial.
Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14. N Engl J Med. 2019. PMID: 30763142 Clinical Trial.
Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide.
Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Le Berre MA, Petrenciuc O, Snapir A, Sarapohja T, Smith MR; ARAMIS Investigators. Fizazi K, et al. N Engl J Med. 2020 Sep 10;383(11):1040-1049. doi: 10.1056/NEJMoa2001342. N Engl J Med. 2020. PMID: 32905676 Clinical Trial.
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta-analysis.
Mori K, Yanagisawa T, Fukuokaya W, Iwatani K, Matsukawa A, Katayama S, Pradere B, Laukhtina E, Rajwa P, Moschini M, Albisinni S, Krajewski W, Cimadamore A, Del Giudice F, Teoh J, Urabe F, Kimura S, Murakami M, Tsuzuki S, Miki J, Miki K, Shariat SF, Kimura T; European Association of Urology-Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Mori K, et al. Among authors: miki k. Int J Urol. 2024 Jan;31(1):25-31. doi: 10.1111/iju.15319. Epub 2023 Oct 15. Int J Urol. 2024. PMID: 37840031 Review.
Prognostic value of PSA bounce after definitive radiotherapy revisited.
Urabe F, Kimura T, Sasaki H, Tashiro K, Iwatani K, Aoki M, Sato S, Takahashi H, Miki K, Egawa S. Urabe F, et al. Among authors: miki k. Int J Clin Oncol. 2022 Feb;27(2):411-417. doi: 10.1007/s10147-021-02053-0. Epub 2021 Oct 22. Int J Clin Oncol. 2022. PMID: 34677737
[Polyorchidism with undiscending testis: a case report].
Shiono Y, Kishimoto K, Furuta N, Miki K, Hatano T, Igarasi H, Oishi Y, Kiyota H. Shiono Y, et al. Among authors: miki k. Nihon Hinyokika Gakkai Zasshi. 2002 Sep;93(6):707-9. doi: 10.5980/jpnjurol1989.93.707. Nihon Hinyokika Gakkai Zasshi. 2002. PMID: 12385096 Free article. Review. Japanese.
69 results